Statistics
Publications
9
Citations
757
H-Index
9
Active since
2011
Maciej Cabanski is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and life sciences.
Publications per year
2011–2023
9
9
Effective “activated PI3Kδ syndrome”–targeted therapy with the PI3Kδ inhibitor leniolisib
V. Koneti Rao, Sharon Webster, Virgil A. S. H. Dalm et al. · Blood · 2017 · 286 citations · Full text
Thomas Dörner, Maximilian Posch, Yue Li et al. · Annals of the Rheumatic Diseases · 2019 · 200 citations
Enforced expression of miR-125b affects myelopoiesis by targeting multiple signaling pathways
Ewa Surdziel, Maciej Cabanski, Iris Dallmann et al. · Blood · 2011 · 91 citations
Martin Kaul, Peter End, Maciej Cabanski et al. · Clinical and Translational Science · 2021 · 81 citations · Full text
1–5 of 9